2020 Pharma Traceability Vendor Directory

The investment not only moves along the company’s efforts in advancing clinical studies, but also opens up 700 new jobs for the Greater Toronto area.

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

The program intends to address supply chain challenges surrounding product safety, traceability, and counterfeiting.

The deal is expected to be finalized by the first half of this year.